
Creating Shit Hot Authentic Stories to Sell Your Achievements
In this episode, Charles talks about how to craft authentic and genuine stories that can sell yourself and stand out from the rest. He points out that many resumes lack persuasive pitches and unique s...
22 Apr 202414min

Discussing radiotherapy, AAA and CEO leadership with Riccardo Canevari: CEO of Radiopharm Theranostics
In this episode, Charles talks with Riccardo Canevari, the managing director and CEO of Radiopharm Theranostics, a company that is innovating the way we see cancer. They talked about his leadership jo...
15 Apr 202439min

Radiotherapy 2024: Quick Look into the Radiotherapy Landscape
In this episode, we're exploring the latest in radiotherapy, especially radioligand therapy for cancer treatment. Charles spotlights some promising trials coming up in 2024 that involve companies like...
8 Apr 202414min

Ilaria Conti VP ADC Therapeutics - Female Leadership, Challenges in ADCs and Working in the US
In this episode, we talk about ADCs or antibody-drug conjugates with Ilaria Contis, a VP at ADC Therapeutics. This Swiss company is a commercial, global leader and pioneer in the field of antibody-dru...
1 Apr 202446min

Masterful Salary Negotiations: Less Fear, More Preparations and Get More of What You Want
In this episode, Charles covers the steps before applying, the application process, and how to negotiate your salary. He also explores the reasons behind the discomforts that may arise during these co...
1 Apr 202417min

Mats Hansen, CEO Spago Nanomedical: How to Lead a Radiotherapy Biotech
In this episode, we explore radiotherapy biotech with Mats Hansen. He is the CEO of Spago Nanomedical AB, a biotech firm advancing cancer treatment with new radiopharmaceuticals. Mats discusses the ch...
1 Apr 202437min

Podcast Trailer
Welcome to “A Dose of Reality”, the podcast where we infuse insight, laughter, and practical wisdom into the world of clinical leadership and career development. Hosted by Charles Spence, each episode...
14 Mars 20241min



















